Abstract: P846 DETECTION OF FAMILIAL HYPERCHOLESTEROLAEMIA IN A COHORT OF CORONARY HEART DISEASE PATIENTS IN WESTERN AUSTRALIA

2009 ◽  
Vol 10 (2) ◽  
pp. e989
Author(s):  
K Liyanage ◽  
J Burnett ◽  
F van Bockxmeer
2020 ◽  
pp. 343-348
Author(s):  
Perry Elliott ◽  
Pier D. Lambiase ◽  
Dhavendra Kumar

Familial hypercholesterolaemia (FH) is an inborn error of metabolism that leads to accumulation of low-density lipoprotein cholesterol (LDL-C) particles in the blood and premature coronary artery atherosclerosis. This chapter covers the clinical criteria for the diagnosis of FH, the genetics that underpins the condition, cascade testing, premature coronary heart disease, and treatment methods.


2021 ◽  
pp. 981-1004
Author(s):  
Fredrik Karpe

This chapter begins with lipids and coronary heart disease, and the assessment of CVD risk in the patient. It describes primary hyperlipidaemias, polygenic and familial hypercholesterolaemia, familial hypertriglyceridaemia, and rare genetic hypertriglyceridaemias. Elevation of Lp(a), rare familial mixed dyslipidaemias, secondary hyperlipidaemias, and drug therapy are all covered.


2000 ◽  
Vol 247 (4) ◽  
pp. 479-484 ◽  
Author(s):  
J. M. Jensen ◽  
L. U. Gerdes ◽  
H. K. Jensen ◽  
T. M. Christiansen ◽  
J. U. Brorholt-Petersen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document